In the first order, I didn't dump on the industry; I dumped on the bill. Those are two very different things. The industry's fantastic. The point that I made is that the bill is awful.
The second point is that my criticism of the Deloitte study is that it only dealt with vitamins and minerals and that it only dealt with hospital settings. It was very, very narrow in scope, and yes, it was commissioned by the industry.
The third point is that most of the issues that you're talking about that affect industry deal with labelling and with cost recovery, which this bill has absolutely nothing to do with. The exact cost.... I'll go back, to be very clear, because you talk about turning a blind eye to criminals. A blind eye to criminals would be giving a $5,000 fine to an incredibly negligent firm. If you are compliant, sir, you have absolutely nothing to fear from this bill. In fact, if you're working to be compliant, you have nothing to fear from this bill. It is only in cases of egregious negligence that these measures kick in. It is not us who adjudicate the penalty, but the courts. I would suggest to you that negligence resulting in potentially a death or somebody being hospitalized is a gross form of negligence that needs to be dealt with in the courts. It would, in fact, be blind—to use your nomenclature—to leave the system in place that would allow that kind of gross negligence to occur.
Lastly, in terms of the Canadian brand, why would you go and buy something from any country other than one that has the best regulatory regime to make sure that it's safe? Whether it's smoke-free Ontario or seat belts, I've heard these arguments again and again: that if you do something that creates safety, you're going to kill business; 10 out of 10 times, that is not the case. There's improved business, improved safety and improved outcomes.